
Dermapharm Investor Relations Material
Latest events

Q1 2025
15 May, 2025

Q4 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dermapharm Holding SE
Access all reports
Dermapharm Holding SE is a Germany-based pharmaceutical company specializing in the development, production, and marketing of branded prescription and over-the-counter (OTC) medicines, dietary supplements, and medical devices. The company focuses on niche markets, offering a diverse portfolio of products across therapeutic areas such as dermatology, allergy, and pain management. Dermapharm also provides contract manufacturing services to third-party pharmaceutical companies. The company is headquartered in Grünwald, Germany, and its shares are listed on the Frankfurt Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
DMP
Country
🇩🇪 Germany